Our Approach

Entering the U.S. national stage requires careful attention to differences in prosecution practice, disclosure standards, and claim interpretation. Our approach emphasizes continuity and discipline, rather than re-inventing strategy at entry.

Our Focus:

• Preserving priority and intended scope

• Translating international-phase strategy into U.S. practice

• Addressing U.S.-specific requirements without unnecessary disruption

• Maintaining consistency across related patent families

Typical Services Include:

• U.S. national stage entry for PCT patent applications

• Review of the international application for U.S. compliance

• Targeted claim adaptation where required by USPTO practice

• Prosecution before the USPTO

• Examiner interviews and reporting

• Strategic input on continuation and claim-set planning

Implementing Your Strategy

We act as U.S. counsel of record for national stage entry and prosecution, working collaboratively with instructing counsel and respecting established mandates.

All substantive decisions are coordinated to ensure alignment with the overall portfolio strategy.

Adjusting Your Claims

Claims suitable in other jurisdictions may require adjustment for the U.S. national stage. Our approach is measured and purpose-driven.

The goal is defensible U.S. scope without unnecessary procedural complexity.

Our Approach:

• Identify claim elements likely to attract U.S. objections

• Propose targeted adjustments only where justified

• Preserve fallback positions consistent with broader strategy

• Advise on continuation practice with restraint

Input as Needed:

• Examiner interviews

• Clear summaries of examiner positions

• Practical explanations of procedural considerations

• Reasoned recommendations for next steps

USPTO Interviews

Where appropriate, we engage directly with USPTO examiners to clarify issues and advance prosecution efficiently

This supports informed decision-making and avoids unnecessary cycles of amendment.

Clear Communication

Our workflow emphasizes clarity, structure, and reliability.

We view disciplined communication as essential to effective long-term collaboration.

No Surprises

• Experienced attorney oversight

• Clear written reporting

• Timely communication aligned with agreed deadlines

• No direct applicant contact unless specifically requested

We Emphasize:

• Defined Scope at U.S. entry

• Transparent fee structures

• Early identification of potential cost drivers

• Avoidance of unnecessary procedural steps

Fee Structure

We recognize the importance of cost predictability in national stage work.

Details regarding U.S. entry of PCT applications and rates are available separately for planning purposes.

Firms choose to work with us because we offer:

• Focused experience in biotech and medical device technologies

• Strong familiarity with USPTO prosecution practice

• A disciplined, non-opportunistic approach to U.S. entry

• Respect for existing counsel relationships

• Clear, predictable communication

Our aim is to provide reliable U.S. national stage representation that fits naturally within a well-managed international portfolio.